A recombinant monoclonal antibody against TP53, its preparation method and application

CN118994386BActive Publication Date: 2025-10-28GANNAN INST OF INNOVATION & TRANSLATIONAL MEDICINE
-1 Cites 0 Cited by

Patent Information

Application Number
CN202411369084.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-29
Publication Date
2025-10-28
Estimated Expiration
2044-09-29

Smart Images

  • Figure CN118994386B_ABST
    Figure CN118994386B_ABST
Patent Text Reader

Abstract

This invention belongs to the field of biotechnology, specifically relating to an anti-TP53 recombinant monoclonal antibody, its preparation method, and its application. The anti-TP53 recombinant monoclonal antibody includes a heavy chain variable region and a light chain variable region; the heavy chain variable region includes any one of the amino acid sequences shown in SEQ ID NO. 6-9; the light chain variable region includes the amino acid sequence shown in SEQ ID NO. 10. This invention utilizes hybridoma technology to prepare a mouse anti-human TP53 recombinant monoclonal antibody. This recombinant antibody has a well-defined structure, high titer, and better stability, effectively solving the problems existing in traditional hybridoma technology.
Need to check novelty before this filing date? Find Prior Art